Obesity and coronary risk in patients treated with second-generation antipsychotics.
about
Obesity and psychotic disorders: uncovering common mechanisms through metabolomicsCardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysisLong-term risperidone treatment induces visceral adiposity associated with hepatic steatosis in mice: a magnetic resonance approachPreliminary and ongoing French multicenter prospective naturalistic study of adverse events of antipsychotic treatment in naive children and adolescents.The impact of incarceration on obesity: are prisoners with chronic diseases becoming overweight and obese during their confinement?Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects.Weight gain and antipsychotics: a drug safety review.Do antipsychotics increase diabetes risk in children and adolescents?Achievement and maintenance of the new impact factor 2010.A study that shows nothing.Post-mortem findings in mood disorders, nightmares and therapeutic approaches of psychiatric diseases.
P2860
Q27011617-C7E8E32C-DDE0-4E12-AFF3-AFBC2B4741C6Q28066750-0F68E11B-7CAE-43FC-A0D1-B5AF3871E947Q33607534-0AB18326-4550-489E-971E-C8EF12A0A7DBQ33835596-4B62B70A-8FCD-46E5-8CEF-7A5FA99580A5Q35238879-4B98470B-E81F-4E36-AB8D-91E1A186A09FQ36423040-B175343B-586C-4ED5-93B8-AF4693CA2DD0Q38268590-02C3515B-861D-44AF-AAF1-98C02284DBA0Q38283956-7CC7FD44-B3C2-4CAB-986B-2B77B71BACFDQ42872962-6D5FFDD3-B836-40A6-B2C2-CFBBDB4FC565Q43467554-D13B32A3-71C8-4731-89E5-7673E4E46FF9Q48218747-7900881C-1A90-42E6-8601-30CDAB5040BD
P2860
Obesity and coronary risk in patients treated with second-generation antipsychotics.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Obesity and coronary risk in patients treated with second-generation antipsychotics.
@ast
Obesity and coronary risk in patients treated with second-generation antipsychotics.
@en
type
label
Obesity and coronary risk in patients treated with second-generation antipsychotics.
@ast
Obesity and coronary risk in patients treated with second-generation antipsychotics.
@en
prefLabel
Obesity and coronary risk in patients treated with second-generation antipsychotics.
@ast
Obesity and coronary risk in patients treated with second-generation antipsychotics.
@en
P2093
P2860
P1476
Obesity and coronary risk in patients treated with second-generation antipsychotics.
@en
P2093
Christoph U Correll
John M Kane
Peter Manu
P2860
P2888
P304
P356
10.1007/S00406-010-0177-Z
P577
2010-12-12T00:00:00Z